{"id":52964,"date":"2023-01-17T10:02:17","date_gmt":"2023-01-17T09:02:17","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/sandki-360-powered-by-mixmove\/"},"modified":"2023-01-17T10:02:17","modified_gmt":"2023-01-17T09:02:17","slug":"sandki-360-powered-by-mixmove","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/sandki-360-powered-by-mixmove\/","title":{"rendered":"SANDKI 360\u00b0 powered by MIXMOVE"},"content":{"rendered":"
\n

\nSkandi Network, the first European active temperature-controlled Life Care distribution network, has announced its partnership with MIXMOVE, a cloud solution that supports logistics by connecting systems, increasing profitability and reducing CO2 emissions. By developing a unique digital collaborative platform (Skandi 360\u00b0 powered by MIXMOVE), different data that flows from all shipments going through the network will be consolidated to ensure end-to-end visibility.<\/b>\n<\/p>\n

DROBAK, Norway & PARIS–(BUSINESS WIRE)–#costreduction<\/a>–Skandi Network is the first unified network for healthcare distribution throughout Europe for human & veterinary healthcare products.\n<\/p>\n

<\/a><\/p>\n

\nThe network offers healthcare temperature-controlled transport for parcels and 1 to 5 pallet(s) shipments throughout 25 countries. Skandi Network is composed of 7 members who are all leading healthcare carriers. The main challenge of the network is to operate cross border transport shipments that involve cross docking operations.\n<\/p>\n

\n\u201cHaving end-to-end visibility is already a challenge with one carrier but operating multi-county and multi-carrier operations at the same time is even more challenging. As we are transporting temperature sensitive healthcare products, we must guarantee that the products are transported in alignment with the GDP regulation and that temperature is monitored and always guaranteed. It is also important that our customers can have access to that information in real time.<\/i>\u201d -Rudy Smets, CEO of Skandi Network.\n<\/p>\n

\nFor these reasons, Skandi Network teamed up with MIXMOVE to develop a unique collaborative platform – Skandi 360\u00b0 – to consolidate all operational and analytical data flows for all shipments going through the network.\n<\/p>\n

\nOne view and one access to the best-in-class healthcare transport network in Europe<\/b>\n<\/p>\n

\nSkandi Network is about giving access to the best-in-class healthcare transport network in Europe, working with 7 domestic leading freight forwarders. Skandi 360\u00b0 will provide a coordinated solution to the market and its different stakeholders, giving them real time access and control of the first pan-European healthcare transport network (having over 4,780 vehicles and 165 temperature-controlled depots).\n<\/p>\n

\nConnecting to Skandi 360\u00b0 will allow them to expand, and\/or optimise, their own capacities in a consolidated approach.\n<\/p>\n

\nCO2 emissions reduction<\/b>\n<\/p>\n

\nIn addition, Skandi 360\u00b0 will also give an opportunity to reduce the carbon footprint and the cost of ownership throughout the whole transport chain. This includes:\n<\/p>\n

\n– Consolidation of flows,\n<\/p>\n

\n– Optimisation of logistics networks via regional distribution centres,\n<\/p>\n

\n– No additional passive packaging needed in the network,\n<\/p>\n

\n– And a reduction of damages and product loss during transport thanks to temperature monitoring.\n<\/p>\n

\nDigitalising Logistics with MIXMOVE<\/b>\n<\/p>\n

\nMIXMOVE can integrate a very large amount of information and data coming from different sources and IT systems (like TMS, telematic systems, WMS, ERP). The MIXMOVE technology turns vertical and independent data flows into a flexible and consolidated One view\/One access to data, all the way up to parcel\/shipment level.\n<\/p>\n

\nMIXMOVE also makes it possible to combine transport network functionalities and collaborative platform functionalities. This enables the management of the transport network in a lean and efficient way, creating real added value for all users of Skandi Network.\n<\/p>\n

\nMIXMOVE tailors its technology to suit specific constraints linked to the healthcare transport business, including the regulations around integrating quality management, real-time temperature follow-up (including corrective and preventive actions), and POD\u2019s that include an end-to-end temperature curve.\n<\/p>\n

\n\u201cWe have chosen MIXMOVE for their proven expertise in the global supply chain and their proven technology to manage complex transport network operations. They use an advanced cloud-based technology with API connectivity. The MIXMOVE solution offers a capability to connect different systems and different tools (TMS, WMS, telematic systems\u2026) seamlessly to the platform. This is what we needed, first to allow all members to be connected, and second to allow all external stakeholders, such as logistic service providers, to plug themselves into the platform and use our network.<\/i>“ \u2013 Rudy Smets, CEO of Skandi Network.<\/i>\n<\/p>\n

\nAbout Skandi Network<\/span><\/b>\n<\/p>\n

\nSkandi Network is the first unified network for healthcare distribution throughout Europe for human & veterinary pharmaceuticals, biomedicals, APIs, temperature sensitive medical devices, diagnostics and general life products that are temperature sensitive. The network provides 2\/8\u00b0C, 15\/25\u00b0C and 20\u00b0C (in passive packaging) transport services and covers 25 countries thanks to the alliance of 7 leading healthcare carriers : Arra Group (Poland), BHS Logistics (Denmark, Sweden, Norway, Finland, Estonia, Latvia, Lithuania), BL Turkey Biopharma Logistics (Turkey), Eurotranspharma (France, Belgium, the Netherlands, Luxemburg, Spain, Czech Republic, Slovakia and also Germany, Austria and Slovenia via its existing local partner), Movianto (England, Scotland, Wales, Northern Ireland), PHSE (Italy), Rangel Logistics Solutions (Portugal). The aim of Skandi Network is to have members covering 36 countries by 2025. In total, the network members have more than 4,000 employees, operating in more than 4,780 temperature-controlled vehicles, 10 strategic regional consolidation platforms, 165 temperature controlled depots and transporting 14,750,000 temperature controlled shipments per year.\n<\/p>\n

\nFor more information : https:\/\/www.skandi-network.com\/<\/a>\n<\/p>\n

\nAbout MIXMOVE<\/span><\/b>\n<\/p>\n

\nMIXMOVE provides a cloud solution supporting logistics by connecting systems, increasing profitability and reducing CO2 emissions.\n<\/p>\n

\nFor more than 10 years, MIXMOVE provides shippers, carriers and logistics service providers, the best customer experience in getting logistics transparency, predictability and resilience.\n<\/p>\n

\nThe main capabilities of the solution are focused on visibility, control and execution of transport & logistics services. Additional capabilities include optimising warehouse operations (like advanced cross-docking), order flow and fulfilment optimisation, planning automatisation, dispatching and routing optimisation.\n<\/p>\n

\nMIXMOVE mobile applications enable digitalisation and collaboration with drivers. Trusted by customers like 3M, Volkswagen TPS, DHL, DSV, and Gebr\u00fcder Weiss, MIXMOVE has a proven track record in delivering high ROI, facilitating collaboration and helping achieve sustainability by improving resource utilisation.\n<\/p>\n

\nFor more information about MIXMOVE: www.mixmove.io<\/a>\n<\/p>\n

Contacts<\/b> <\/p>\n

\nRudy SMETS
\n
CEO
\n
mail@skandi-network.com<\/a>\n<\/p>\n

\nDoroth\u00e9e DOSSMANN
\n
Head of Marketing
\n
dorothee.dossmann@mixmove.io<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Skandi Network, the first European active temperature-controlled Life Care distribution network, has announced its partnership with MIXMOVE, a cloud solution that supports logistics by connecting systems, increasing profitability and reducing CO2 emissions. By developing a unique digital collaborative platform (Skandi 360\u00b0 powered by MIXMOVE), different data that flows from all shipments going through the network … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-52964","6":"format-standard","7":"category-industry"},"yoast_head":"\nSANDKI 360\u00b0 powered by MIXMOVE - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/sandki-360-powered-by-mixmove\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SANDKI 360\u00b0 powered by MIXMOVE - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Skandi Network, the first European active temperature-controlled Life Care distribution network, has announced its partnership with MIXMOVE, a cloud solution that supports logistics by connecting systems, increasing profitability and reducing CO2 emissions. By developing a unique digital collaborative platform (Skandi 360\u00b0 powered by MIXMOVE), different data that flows from all shipments going through the network ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/sandki-360-powered-by-mixmove\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-17T09:02:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230117005252\/en\/1686650\/21\/Logo_mixmove_-_bicolored_-_gray_-_M_-_RGB.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sandki-360-powered-by-mixmove\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sandki-360-powered-by-mixmove\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"SANDKI 360\u00b0 powered by MIXMOVE\",\"datePublished\":\"2023-01-17T09:02:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sandki-360-powered-by-mixmove\\\/\"},\"wordCount\":921,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sandki-360-powered-by-mixmove\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230117005252\\\/en\\\/1686650\\\/21\\\/Logo_mixmove_-_bicolored_-_gray_-_M_-_RGB.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sandki-360-powered-by-mixmove\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sandki-360-powered-by-mixmove\\\/\",\"name\":\"SANDKI 360\u00b0 powered by MIXMOVE - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sandki-360-powered-by-mixmove\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sandki-360-powered-by-mixmove\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230117005252\\\/en\\\/1686650\\\/21\\\/Logo_mixmove_-_bicolored_-_gray_-_M_-_RGB.jpg\",\"datePublished\":\"2023-01-17T09:02:17+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sandki-360-powered-by-mixmove\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sandki-360-powered-by-mixmove\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sandki-360-powered-by-mixmove\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230117005252\\\/en\\\/1686650\\\/21\\\/Logo_mixmove_-_bicolored_-_gray_-_M_-_RGB.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230117005252\\\/en\\\/1686650\\\/21\\\/Logo_mixmove_-_bicolored_-_gray_-_M_-_RGB.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sandki-360-powered-by-mixmove\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"SANDKI 360\u00b0 powered by MIXMOVE\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SANDKI 360\u00b0 powered by MIXMOVE - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/sandki-360-powered-by-mixmove\/","og_locale":"en_US","og_type":"article","og_title":"SANDKI 360\u00b0 powered by MIXMOVE - Pharma Trend","og_description":"Skandi Network, the first European active temperature-controlled Life Care distribution network, has announced its partnership with MIXMOVE, a cloud solution that supports logistics by connecting systems, increasing profitability and reducing CO2 emissions. By developing a unique digital collaborative platform (Skandi 360\u00b0 powered by MIXMOVE), different data that flows from all shipments going through the network ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/sandki-360-powered-by-mixmove\/","og_site_name":"Pharma Trend","article_published_time":"2023-01-17T09:02:17+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230117005252\/en\/1686650\/21\/Logo_mixmove_-_bicolored_-_gray_-_M_-_RGB.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/sandki-360-powered-by-mixmove\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/sandki-360-powered-by-mixmove\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"SANDKI 360\u00b0 powered by MIXMOVE","datePublished":"2023-01-17T09:02:17+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/sandki-360-powered-by-mixmove\/"},"wordCount":921,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/sandki-360-powered-by-mixmove\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230117005252\/en\/1686650\/21\/Logo_mixmove_-_bicolored_-_gray_-_M_-_RGB.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/sandki-360-powered-by-mixmove\/","url":"https:\/\/pharma-trend.com\/en\/sandki-360-powered-by-mixmove\/","name":"SANDKI 360\u00b0 powered by MIXMOVE - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/sandki-360-powered-by-mixmove\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/sandki-360-powered-by-mixmove\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230117005252\/en\/1686650\/21\/Logo_mixmove_-_bicolored_-_gray_-_M_-_RGB.jpg","datePublished":"2023-01-17T09:02:17+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/sandki-360-powered-by-mixmove\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/sandki-360-powered-by-mixmove\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/sandki-360-powered-by-mixmove\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230117005252\/en\/1686650\/21\/Logo_mixmove_-_bicolored_-_gray_-_M_-_RGB.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230117005252\/en\/1686650\/21\/Logo_mixmove_-_bicolored_-_gray_-_M_-_RGB.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/sandki-360-powered-by-mixmove\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"SANDKI 360\u00b0 powered by MIXMOVE"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/52964","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=52964"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/52964\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=52964"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=52964"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=52964"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}